Literature DB >> 8477715

Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptor-mediated endocytosis.

A Bérczi1, M Ruthner, V Szüts, M Fritzer, E Schweinzer, H Goldenberg.   

Abstract

The influence of conjugation of doxorubicin to holotransferrin on the receptor-mediated endocytosis of and on the iron uptake from transferrin was studied using K562 cells. 125I-labelled transferrin and doxorubicin-transferrin conjugates were used in the binding, dissociation, and ligand-exchange experiments at 0 degree C, and 59Fe,125I-labelled (double-labelled) ligands were used in the endocytosis, iron uptake, and recycling experiments at 37 degrees C. The binding affinity of conjugates was about half of that of transferrin. Binding of 125I-labelled ligands was blocked by both unlabelled ligands to the same degree, however, it was not blocked at all by an 8000-fold excess of doxorubicin. After saturation bindings, slightly more 125I-labelled conjugates dissociated from the surface of cells than transferrin. Exchange of 125I-labelled ligands for unlabelled ligands resulted in different EC50 values (defined as the concentration of unlabelled ligand at which half as much radioligand is exchanged for unlabelled ligand as would be exchanged at infinitely high concentration of unlabelled ligand under similar assay conditions). While transferrin exchanged transferrin with an EC50 value close to the binding affinity, conjugates exchanged conjugates with much lower efficiency. The heterolog exchange experiments yielded EC50 values inbetween the two extrema. For studying iron uptake, K562 cells were loaded with the double-labelled ligands either at 37 degrees C (endosome-loading only) or at 0 degree C (surface-loading only). Results obtained for the endocytosis of, the iron uptake from, and the recycling of double-labelled ligands indicate that (a) the rate of iron uptake is smaller from conjugates than from transferrin, (b) there are at least two parallel recycling processes for both ligand.receptor complexes, and (c) each time constant characterizing the different steps of iron uptake via receptor-mediated endocytosis is smaller for conjugates than for transferrin (or, the half times characterizing the different steps are higher for conjugates than for transferrin). Endocytosis and iron uptake were unaffected by free doxorubicin (12.5 microM) or colchicine (1 mM). Benzyl alcohol (30 mM) slowed down the rate of both endocytosis and iron uptake, while dithiothreitol (5 mM) decreased the rate of iron uptake and increased the rate of endocytosis. N-Ethylmaleimide (1 mM) completely stopped both endocytosis and iron uptake. The results suggest that the binding of conjugates to the surface of cells is governed by the binding of the transferrin part of conjugates to the transferrin receptor. However, conjugation of doxorubicin to transferrin seems to influence all properties of transferrin.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477715     DOI: 10.1111/j.1432-1033.1993.tb17778.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting.

Authors:  Tae Hyung Kim; Young Gi Jo; Hai Hua Jiang; Sung Mook Lim; Yu Seok Youn; Seulki Lee; Xiaoyuan Chen; Youngro Byun; Kang Choon Lee
Journal:  J Control Release       Date:  2012-07-21       Impact factor: 9.776

2.  Preparation and investigation of bioactive transferrin-iron complexes formed with different synergistic anions.

Authors:  Judit Gálicza; Andrea Vargová; Viktor Sándor; Csongor Kálmán Orbán; Csaba Dezso András; Beáta Abrahám; Szabolcs Lányi; Ferenc Kilár
Journal:  Protein J       Date:  2012-01       Impact factor: 2.371

3.  Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin.

Authors:  Marzena Szwed; Katarzyna D Kania; Zofia Jozwiak
Journal:  Cell Oncol (Dordr)       Date:  2014-11-20       Impact factor: 6.730

4.  Doxorubicin-transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells.

Authors:  Paulina Wigner; Krzysztof Zielinski; Magdalena Labieniec-Watala; Agnieszka Marczak; Marzena Szwed
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

5.  Transferrin-Bound Doxorubicin Enhances Apoptosis and DNA Damage through the Generation of Pro-Inflammatory Responses in Human Leukemia Cells.

Authors:  Monika Jedrzejczyk; Katarzyna Wisniewska; Katarzyna Dominika Kania; Agnieszka Marczak; Marzena Szwed
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

6.  Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation.

Authors:  Marzena Szwed; Audrey Laroche-Clary; Jacques Robert; Zofia Jozwiak
Journal:  Cell Oncol (Dordr)       Date:  2015-11-26       Impact factor: 6.730

7.  Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.

Authors:  Dorota Łubgan; Zofia Jóźwiak; Gerhard G Grabenbauer; Luitpold V R Distel
Journal:  Cell Mol Biol Lett       Date:  2008-10-10       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.